- Home
- UPWK vs SPRY Comparison
UPWK vs SPRY Comparison
Compare UPWK & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPWK
- SPRY
- Stock Information
- Founded
- UPWK 2013
- SPRY 2015
- Country
- UPWK United States
- SPRY United States
- Employees
- UPWK N/A
- SPRY N/A
- Industry
- UPWK EDP Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- UPWK Technology
- SPRY Health Care
- Exchange
- UPWK Nasdaq
- SPRY Nasdaq
- Market Cap
- UPWK 1.7B
- SPRY 1.4B
- IPO Year
- UPWK 2018
- SPRY N/A
- Fundamental
- Price
- UPWK $15.49
- SPRY $14.43
- Analyst Decision
- UPWK Buy
- SPRY Strong Buy
- Analyst Count
- UPWK 14
- SPRY 4
- Target Price
- UPWK $18.77
- SPRY $28.75
- AVG Volume (30 Days)
- UPWK 2.5M
- SPRY 1.5M
- Earning Date
- UPWK 05-05-2025
- SPRY 05-14-2025
- Dividend Yield
- UPWK N/A
- SPRY N/A
- EPS Growth
- UPWK 373.01
- SPRY N/A
- EPS
- UPWK 1.66
- SPRY N/A
- Revenue
- UPWK $771,094,000.00
- SPRY $97,122,000.00
- Revenue This Year
- UPWK $0.26
- SPRY $1.49
- Revenue Next Year
- UPWK $5.76
- SPRY $141.68
- P/E Ratio
- UPWK $9.34
- SPRY N/A
- Revenue Growth
- UPWK 7.21
- SPRY 971120.00
- 52 Week Low
- UPWK $8.43
- SPRY $7.55
- 52 Week High
- UPWK $18.14
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- UPWK 50.35
- SPRY 53.24
- Support Level
- UPWK $16.05
- SPRY $14.32
- Resistance Level
- UPWK $16.12
- SPRY $15.50
- Average True Range (ATR)
- UPWK 0.41
- SPRY 0.84
- MACD
- UPWK -0.23
- SPRY 0.12
- Stochastic Oscillator
- UPWK 9.24
- SPRY 72.21
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.